Home › NDC Lookup › RxCUI directory › RxCUI 1359363

Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Topical Ointment — RxCUI 1359363

RxNorm drug concept · Semantic clinical drug
RxCUI 1359363 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1359363
Official nameBacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM Topical Ointment
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Neomycin, Polymyxin, and Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a first-aid antibiotic you apply to small, everyday wounds — minor cuts, scrapes, and burns — to help prevent a bacterial infection from developing. Some products also help te...
  • What is this triple antibiotic ointment actually for?
  • Start by cleaning the wound area. Then apply a small amount — about the size of your fingertip — directly on the area up to 1 to 3 times a day. You can cover it with a sterile band...
  • Most people don't have any trouble with it. The most common reaction is a mild skin irritation, redness, itching, or swelling at the spot you applied it. If you use it often, you c...
📖 Read our full Neomycin, Polymyxin, and Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Topical Ointment RxCUI 1359363

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Bacitracin 1291
    • Neomycin 7299
    • Polymyxin B 8536
    • Bacitracin / neomycin / polymyxin B 477619
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bacitracin / neomycin / polymyxin B Topical Ointment 376031
    • Bacitracin / neomycin / polymyxin B Topical Product 1155351
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Bacitracin 0.5 UNT/MG 315454
    • Neomycin 0.0035 MG/MG 328185
    • Polymyxin B 10 UNT/MG 328475

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bacitracin 0.5 UNT/MG SCDC · 315454
  • Neomycin 0.0035 MG/MG SCDC · 328185
  • Polymyxin B 10 UNT/MG SCDC · 328475
  • Bacitracin / neomycin / polymyxin B Topical Ointment SCDF · 376031
  • Bacitracin / neomycin / polymyxin B Topical Product SCDG · 1155351

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1359363 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0018-56 1 TUBE in 1 CARTON (0363-0018-56) / 28 g in 1 TUBE Antibiotic Maximum Strength Walgreens 1998-06-16
00363-1331-01 1 TUBE in 1 CARTON (0363-1331-01) / 28 g in 1 TUBE ANTIBIOTIC Maximum Strength Walgreens Co. 2025-01-29
54473-0291-01 14 g in 1 TUBE (54473-291-01) Triple Antibiotic Melaleuca, Inc. 2018-01-01
85248-0117-01 20 g in 1 TUBE (85248-117-01) DERMFREE Triple Antibiotic Jiangxi Yudexi Pharmaceutical Co., LTD 2026-02-09
85248-0169-01 .5 g in 1 BAG (85248-169-01) sojo Triple Antibiotic Jiangxi Yudexi Pharmaceutical Co., LTD 2026-03-21
Observed labelers: Jiangxi Yudexi Pharmaceutical Co., LTD (2) · Melaleuca, Inc. (1) · Walgreens (1) · Walgreens Co. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.